Tae-Sook Jeong

Dr. Tae-Sook Jeong

Korea Research Institute of Bioscience and Biotechnology
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2008 in Archives of Pharmacal Research
Verified
Journal Article
Closed access
PDF file
MKMin-Jung Kim
Min-Jung Kim
JHJong-Min Han
Jong-Min Han
YJYue-Yan Jin
Yue-Yan Jin
NBNam-In Baek
Nam-In Baek
MBMyun-Ho Bang
Myun-Ho Bang
TJTae-Sook Jeong
Tae-Sook Jeong

1 April 2017 in International Immunopharmacology
Verified
Journal Article
Closed access
HLHua Li
Hua Li
JYJeong-Hyun Yoon
Jeong-Hyun Yoon
HWHyo-Jun Won
Hyo-Jun Won
HJHyeon-Seon Ji
Hyeon-Seon Ji
HYHeong Joo Yuk
Heong Joo Yuk
TJTae-Sook Jeong
Tae-Sook Jeong

3 August 2015 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
HLHua Li
Hua Li
HJHyeon-Seon Ji
Hyeon-Seon Ji
JKJi-Hyun Kang
Ji-Hyun Kang
DSDong-Ha Shin
Dong-Ha Shin
HPHo-Yong Park
Ho-Yong Park
TJTae-Sook Jeong
Tae-Sook Jeong

21 September 2011 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
JKJi-Eun Kim
Ji-Eun Kim
SJSeon-Min Jeon
Seon-Min Jeon
KPKi Hun Park
Ki Hun Park
WLWoo Song Lee
Woo Song Lee
TJTae-Sook Jeong
Tae-Sook Jeong
MCMyung-Sook Choi
Myung-Sook Choi
Background: Natural food supplements with high flavonoid content are often claimed to promote weight-loss and lower plasma cholesterol in animal studies, but human studies have been more equivocal. The aim of this study was firstly to determine the effectiveness of natural food supplements containing Glycine max leaves extract (EGML) or Garcinia cambogia extract (GCE) to promote weight-loss and lower plasma cholesterol. Secondly to examine whether these supplements have any beneficial effect on lipid, adipocytokine or antioxidant profiles. Methods: Eighty-six overweight subjects (Male:Female = 46:40, age: 20~50 yr, BMI > 23 < 29) were randomly assigned to three groups and administered tablets containing EGML (2 g/day), GCE (2 g/day) or placebo (starch, 2 g/day) for 10 weeks. At baseline and after 10 weeks, body composition, plasma cholesterol and diet were assessed. Blood analysis was also conducted to examine plasma lipoproteins, triglycerides, adipocytokines and antioxidants. Results: EGML and GCE supplementation failed to promote weight-loss or any clinically significant change in %body fat. The EGML group had lower total cholesterol after 10 weeks compared to the placebo group (p < 0.05). EGML and GCE had no effect on triglycerides, non-HDL-C, adipocytokines or antioxidants when compared to placebo supplementation. However, HDL-C was higher in the EGML group (p < 0.001) after 10 weeks compared to the placebo group. Conclusions: Ten weeks of EGML or GCE supplementation did not promote weight-loss or lower total cholesterol in overweight individuals consuming their habitual diet. Although, EGML did increase plasma HDL-C levels which is associated with a lower risk of atherosclerosis.


1 August 2015 in Journal of Medicinal Food
Verified
Journal Article
Closed access
HLHua Li
Hua Li
JKJi-Hyun Kang
Ji-Hyun Kang
JHJong-Min Han
Jong-Min Han
MCMoon-Hee Cho
Moon-Hee Cho
YCYoung-Jin Chung
Young-Jin Chung
TJTae-Sook Jeong
Tae-Sook Jeong
The anti-obesity effects of extracts from soy leaves (SLE) cultivated for 8 weeks (8W) or 16 weeks (16W) were investigated in diet-induced obese mice. The effects of kaempferol, an aglycone of the kaempferol glycosides that are the major component of 8W-SLE, and coumestrol, the major component of 16W-SLE, were also investigated in 3T3-L1 adipocytes. Eight-week-old male C57BL/6J mice were randomly divided into normal diet, high-fat diet (HFD), 8W-SLE (HFD+8W-SLE 50 mg kg−1 day−1), 16W-SLE (HFD+16W-SLE 50 mg kg−1 day−1), and Garcinia cambogia extracts (GE) (HFD+GE 50 mg kg−1 day−1) groups. Body weight gain and fat accumulation of white adipose tissue (WAT) were highly suppressed by daily oral administration of 8W-SLE and 16W-SLE for 10 weeks. Supplementing a HFD with 8W-SLE and 16W-SLE regulated the mRNA expression of peroxisome proliferator-activated receptor gamma (PPARγ), CCAAT/enhancer-binding protein alpha (c/EBPα), sterol regulatory element-binding protein-1 (SREBP-1), adipocyte protein 2, and fatty acid synthase (FAS), which are related to adipogenesis, in addition to hormone-sensitive lipase (HSL), carnitine palmitoyl transferase 1 (CPT-1), and uncoupling protein 2 (UCP2), which are related to fat oxidation in WAT. In 3T3-L1 adipocytes, kaempferol and coumestrol exhibited anti-adipogenic effects via downregulation of PPARγ, c/EBPα, SREBP-1, and FAS. Kaempferol and coumestrol increased the expression of HSL, CPT-1, and UCP2.